Corium International Inc. (NASDAQ:CORI) – Equities researchers at Jefferies Group issued their Q1 2017 EPS estimates for shares of Corium International in a note issued to investors on Wednesday. Jefferies Group analyst D. Steinberg expects that the firm will post earnings of ($0.50) per share for the quarter. Jefferies Group has a “Buy” rating and a $9.00 price target on the stock. Jefferies Group also issued estimates for Corium International’s Q2 2017 earnings at ($0.51) EPS, FY2017 earnings at ($1.88) EPS, FY2018 earnings at ($1.55) EPS, FY2019 earnings at ($2.12) EPS and FY2020 earnings at ($1.41) EPS.
A number of other brokerages have also commented on CORI. Needham & Company LLC reissued a “buy” rating and set a $15.00 price target on shares of Corium International in a research note on Monday, September 26th. Zacks Investment Research lowered Corium International from a “hold” rating to a “sell” rating in a research note on Tuesday, October 11th. FBR & Co set a $18.00 price target on Corium International and gave the company a “buy” rating in a research note on Friday, August 5th. Finally, Leerink Swann set a $16.00 price objective on Corium International and gave the company a “buy” rating in a research report on Tuesday, November 22nd. One analyst has rated the stock with a sell rating, one has given a hold rating and four have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus target price of $12.25.
Shares of Corium International (NASDAQ:CORI) opened at 5.51 on Monday. Corium International has a 52-week low of $3.14 and a 52-week high of $9.93. The company’s market capitalization is $122.36 million. The company’s 50 day moving average price is $5.02 and its 200 day moving average price is $4.72.
A hedge fund recently bought a new stake in Corium International stock. Paloma Partners Management Co purchased a new stake in Corium International Inc. (NASDAQ:CORI) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 43,789 shares of the biopharmaceutical company’s stock, valued at approximately $152,000. Paloma Partners Management Co owned 0.20% of Corium International at the end of the most recent quarter. Hedge funds and other institutional investors own 88.40% of the company’s stock.
About Corium International